Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 0 | 83,190 |
| Other current assets | 0 | 0 | 0 | 0 | 1,219 |
| TOTAL | $0 | $0 | $N/A | $0 | $84,409 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 8,687 |
| Investments And Advances | 0 | 0 | 0 | 0 | 376 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 1,346 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $10,409 |
| Total Assets | $0 | $0 | $N/A | $0 | $102,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 2,151 |
| Accrued Expenses | 0 | 0 | N/A | 0 | 3,425 |
| TOTAL | $0 | $0 | $N/A | $0 | $7,946 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $147 |
| Total Liabilities | $0 | $0 | $N/A | $0 | $17,973 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | 0 | 1 |
| Retained earnings | 0 | 0 | N/A | 0 | -110,671 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 162,147 |
| TOTAL | $0 | $0 | $N/A | $0 | $84,616 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $102,589 |